nach oben

Calcified Tissue International

Erschienen in:

01.09.2015 | Original Research

The Role of Collagen Organization on the Properties of Bone

verfasst von: Patrick Garnero

Erschienen in: Calcified Tissue International | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Bone is a complex tissue constituted by a collagen matrix filled in with crystal of hydroxyapatite (HAP). Bone mechanical properties are influenced by the collagen matrix which is organized into hierarchical structures from the individual type I collagen heterotrimer flanked by linear telopeptides at each end to the collagen fibrils that are interconnected by enzymatic and non-enzymatic cross-links. Although most studies focused on the role of collagen cross-links in bone strength, other organizational features may also play a role. At the molecular level it has been shown that homotrimer of type I collagen found in bone tissue of some patients with osteogenesis imperfecta (OI) is characterized by decreased mechanical competence compared to the regular heterotrimer. The state of C-telopeptide isomerization—which can be estimated by the measurement in body fluids of the native and isomerized isoforms—has also been shown to be associated with bone strength, particularly the post-yield properties independent of bone size and bone mineral density. Other higher hierarchical features of collagen organization have shown to be associated with changes in bone mechanical behavior in ex vivo models and may also be relevant to explain bone fragility in diseases characterized by collagen abnormalities e.g., OI and Paget’s disease. These include the orientation of collagen fibrils in a regular longitudinal direction, the D-spacing period between collagen fibrils and the collagen-HAP interfacial bonding. Preliminary data indicate that some of these organizational features can change during treatment with bisphosphonate, raloxifene, and PTH suggesting that they may contribute to their anti-fracture efficacy. It remains however to be determined which of these parameters play a specific and independent role in bone matrix properties, what is the magnitude of mechanical strength explained by collagen organization, whether they are relevant to explain osteoporosis-induced bone fragility, and how they could be monitored non-invasively to develop efficient bone quality biomarkers.

Schuit SC, van der Klift M, Weel AE, de Laet CE, Burger H, Seeman E, Hofman A, Uitterlinden AG, van Leewen JP, Pols HA (2004) Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone 34:195–202PubMedCrossRef

Sornay-Rendu E, Munoz F, Garnero P, Duboeuf F, Delmas PD (2005) Identification of osteopenic women at high risk of fracture: the OFELY Study. J Bone Miner Res 20:1813–1819PubMedCrossRef

Nyman JS, Reyes M, Wang X (2005) Effect of ultrastructural changes on the toughness of bone. Micron 35:566–582CrossRef

Nyman JS, Roy A, Tyler JH, Acuna RL, Gayle HJ, Wang X (2007) Age-related factors affecting the postyield energy dissipation of human cortical bone. J Orthop Res 25:646–655PubMedCentralPubMedCrossRef

Wang X, Bank RA, Tekoppele JM, Agrawal CM (2001) The role of collagen in determining bone mechanical properties. J Orthop Res 19:1021–1026PubMedCrossRef

Stefan U, Michael B, Werner S (2010) Effects of three different preservation methods on the mechanical properties of human and bovine cortical bone. Bone 47:1048–1053PubMedCrossRef

Currey JD, Foreman J, Laketic I, Mitchell J, Pegg DE, Reilly GC (1997) Effects of ionizing radiation on the mechanical properties of human bone. J Orthop Res 15:111–117PubMedCrossRef

Barth HD, Launey ME, Macdowell AA, Ager JW 3rd, Ritchie RO (2010) On the effect of X-ray irradiation on the deformation and fracture behavior of human cortical bone. Bone 46:1475–1485PubMedCrossRef

Burton B, Gaspar A, Josey D, Tupy J, Grynpas MD, Willet T (2014) Bone embrittlement and collagen modifications due to high—dose gamma-irradiation sterilization. Bone 61:71–81PubMedCrossRef

10.

Stroga GE, Vashishth D (2012) Effects of bone matrix proteins on fracture and fragility in osteoporosis. Curr Osteoporos Rep 10:141–150CrossRef

11.

Niyibizi C, Eyre DR (1989) Bone type V collagen: chain composition and location of a trypsin cleavage site. Connect Tissue Res 20:247–250PubMedCrossRef

12.

Nimni ME (1993) Fibrillar collagens: their biosynthesis, molecular structure, and mode of assembly. In: Zern MA, Reid LM (eds) Extracellular matrix: chemistry, biology, and pathobiology with emphasis on the liver. Marcel Dekker Inc., New York, pp 121–148

13.

Berg RA, Prockop DJ (1973) The thermal transition of a non-hydroxylated form of collagen. Evidence for a role for hydroxyproline in stabilizing the triple-helix of collagen. Biochem Biophys Res Commun 52:115–120PubMedCrossRef

14.

Harwood R, Grant ME, Jackson DS (1975) Studies on the glycosylation of hydroxylysine residues during collagen biosynthesis and the subcellular localization of collagen galactosyltransferase and collagen glucosyltransferase in tendon and cartilage cells. Biochem J 152:291–302PubMedCentralPubMed

15.

Gineyts E, Garnero P, Delmas PD (2001) Urinary excretion of glucosyl-galactosyl pyridinoline: a specific biochemical marker of synovium degradation. Rheumatology (Oxford) 40:315–323CrossRef

16.

Pinnell SR, Fox R, Krane SM (1971) Human collagens: differences in glycosylated hydroxylysines in skin and bone. Biochim Biophys Acta 229:119–122PubMedCrossRef

17.

Petruska JA, Hodge AJ (1964) A subunit model for the tropocollagen macromolecule. Proc Natl Acad Sci USA 51:871–876PubMedCentralPubMedCrossRef

18.

Fledelius C, Johnsen AH, Cloos PA, Bode M, Qvist P (1997) Characterization of urinary degradation products derived from type I collagen. Identification of a beta-isomerized Asp-Gly sequence within the C-terminal telopeptides (alpha 1) region. J Biol Chem 272(15):9755–9763PubMedCrossRef

19.

Cloos PA, Fledelius C (2000) Collagen fragments in urine derived from bone resorption are highly racemized and isomerized: a biological clock of protein aging with clinical potential. Biochem J 345:473–480PubMedCentralPubMedCrossRef

20.

Borel O, Gineyts E, Bertholon C, Garnero P (2012) Cathepsin K preferentially solubilizes matured bone matrix. Calcif Tissue Int 911:32–39CrossRef

21.

Garnero P, Borel O, Gineyts E, Duboeuf F, Solberg H, Bouxsein ML, Christiansen C, Delmas PD (2006) Extracellular post-translational modifications of collagen are major determinants of biomechanical properties of fetal bovine cortical bone. Bone 38:300–309PubMedCrossRef

22.

Garnero P, Fledelius C, Gineyts E, Serre CM, Vignot E, Delmas PD (1997) Decreased beta-isomerization of the C-terminal telopeptide of type I collagen alpha 1 chain in Paget’s disease of bone. J Bone Miner Res 12:1407–1415PubMedCrossRef

23.

Leeming DJ, Delling G, Koizumi M, Henriksen K, Karsdal MA, Li B, Qvist P, Tanko LB, Byrjalsen I (2006) Alpha CTX as a biomarker of skeletal invasion of breast cancer: immunolocalization and the load dependency of urinary excretion. Cancer Epidemiol Biomarkers Prev 15:1392–1395PubMedCrossRef

24.

Kuznetsova N, McBride DJ Jr, Leikin S (2001) Osteogenesis imperfecta murine: interaction between type I collagen homotrimers. J Mol Biol 309:807–815PubMedCrossRef

25.

Jimenez SA, Bashey RI, Yankowski R (1977) Identification of collagen alpha1(I) trimer in embryonic chick tendons and calvaria. Biochem Biophys Res Commun 78:1354–1361PubMedCrossRef

26.

Rojkind M, Giambrone MA, Biempica L (1979) Collagen types in normal and cirrhotic liver. Gastroenterology 76:710–719PubMed

27.

Makareeva E, Han S, Leikin S (2010) Carcinomas contain a matrix metalloproteinase-resistant isoform of type I collagen exerting selective support to invasion. Cancer Res 70:4366–4374PubMedCentralPubMedCrossRef

28.

Rupard JH, Dimar SJ, Haralson MA (1988) Synthesis of type I homotrimer collagen molecules by cultured human lung adenocarcinoma cells. Am J Pathol 133:316–326PubMedCentralPubMed

29.

Bailey AJ, Sims TJ, Knott L (2002) Phenotypic expression of osteoblast collagen in osteoarthritic bone: production of type I homotrimer. Int J Biochem Cell Biol 34:176–182PubMedCrossRef

30.

Mann V, Hobson EE, Li B, Stewart TL, Grant SF, Robins SP, Aspden RM, Ralston SH (2001) A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality. J Clin Invest 107:899–907PubMedCentralPubMedCrossRef

31.

Grant SF, Reid DM, Blake G, Herd R, Fogelman I, Ralston SH (1996) Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha 1 gene. Nat Genet 14:203–205PubMedCrossRef

32.

Mann V, Ralston SH (2003) Meta-analysis of COL1A1 Sp1 polymorphism in relation to bone mineral density and osteoporotic fracture. Bone 32:711–717PubMedCrossRef

33.

Ralston SH, Uitterlinden AG, Brandi ML, Balcells S, Langdahl BL, Lips P, Lorenc R, Obermayer-Pietsch B, Scollen S, Bustamante M, Husted LB, Carey AH, Diez-Perez A, Dunning AM, Falchetti A, Karczmarewicz E, Kruk M, van Leeuwen JP, van Meurs JB, Mangion J, McGuigan FE, Mellibovsky L, del Monte F, Pols HA, Reeve J, Reid DM, Renner W, Rivadeneira F, van Schoor NM, Sherlock RE, Ioannidis JP (2006) Large-scale evidence for the effect of the COLIA1 Sp1 polymorphism on osteoporosis outcomes: the GENOMOS study. PLoS Med 3:e90PubMedCentralPubMedCrossRef

34.

Saban J, Zussman M, King D (1996) Heterozygous oim mice exhibit a mild form of osteogenesis imperfecta. Bone 19:575–579PubMedCrossRef

35.

Misof K, Landis WJ, Fratzl P (1997) Collagen from the osteogenesis imperfecta mouse model (oim) shows reduced resistance against tensile stress. J Clin Invest 100:40–45PubMedCentralPubMedCrossRef

36.

Camacho NP, Hou L, Boskey AL (1999) The material basis for reduced mechanical properties in oim mice bones. J Bone Miner Res 14:264–272PubMedCrossRef

37.

Miller E, Delos D, Pleshko Camacho N (2007) Abnormal mineral-matrix interactions are a significant contributor to fragility in oim/oim bone. Calcif Tissue Int 81:206–214PubMedCentralPubMedCrossRef

38.

McBride DJ, Choe V, Brodsky B (1997) Altered collagen structure in mouse tail tendon lacking the alpha 2(I) chain. J Mol Biol 270:275–284PubMedCrossRef

39.

Miles CA, Sims TJ, Bailey AJ (2002) The role of the alpha2 chain in the stabilization of the collagen type I heterotrimer: a study of the type I homotrimer in oim mouse tissues. J Mol Biol 321:797–805PubMedCrossRef

40.

Nelson MT, Humphrey W, Schulten K (1996) NAMD: a parallel, object-oriented molecular dynamics program. Int J High Perform Comput Appl 10:251–268CrossRef

41.

MacKerell AD, Bashford D, Karplus M (1998) All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B 102:3586–3616PubMedCrossRef

42.

Chang S-W, Shefelbine SJ, Buehler MJ (2012) Structural and mechanical differences between collagen homo- and heterotrimers: relevance for the molecular origin of brittle bone disease. Biophys J 102:640–648PubMedCentralPubMedCrossRef

43.

Viguet-Carrin S, Roux JP, Arlot ME, Merabet Z, Leeming DJ, Byrjalsen I, Delmas PD, Bouxtein M (2006) Contribution of the advanced glycation end product pentosidine and of maturation of type I collagen to compressive biomechanical properties of human lumbar vertebrae. Bone 39:1073–1079PubMedCrossRef

44.

Goldman HM, Bromage TG, Thomas CD, Clement JG (2003) Preferred collagen fiber orientation in the human mid-shaft femur. Anat Rec A 272:434–445CrossRef

45.

Hert J, Fiala P, Petryl M (1994) Osteon orientation of the diaphysis of the long bones in man. Bone 15:269–277PubMedCrossRef

46.

Martin RB, Boardman DL (1993) The effects of collagen fiber orientation, porosity, density, and mineralization bovine cortical bone bending properties. J Biomech 26:1047–1054PubMedCrossRef

47.

Martin RB, Lau ST, Mathews PV, Gibson VA, Stovert SM (1996) Collagen fiber organization is related to mechanical properties and remodelling in equine bone. A comparison of two methods. J Biomechanics 29:1515–1521

48.

Ramasamya JG, Akkusb O (2007) Local variations in the micromechanical properties of mouse femur: the involvement of collagen fiber orientation and mineralization. J Biomech 40:910–918CrossRef

49.

Silva MJ, Brodt MB, Ettner SL (2002) Long bones from the senescence accelerated mouse SAMP6 have increased size but reduced whole-bone strength and resistance to fracture. J Bone Miner Res 17:1597–1603PubMedCrossRef

50.

Silva MJ, Brodt MD, Wopenka B, Thomopoulos S, Williams D, Wassen MHM, Ko M, Kusano N, Bank RA (2006) Decreased collagen organization and content are associated with reduced strength of demineralized and intact bone in the SAMP6 mouse. J Bone Miner Res 21:78–88PubMedCrossRef

51.

Puustjarvi K, Nieminen J, Rasanen T, Hyttinen M, Helminen HJ, Kroger H, Huuskonen J, Alhava E, Kovanen V (2003) Do more highly organized collagen fibrils increase bone mechanical strength in loss of mineral density after one-year running training? J Bone Miner Res 14:321–329CrossRef

52.

Mikkonen L, Tuominen T, Kulonen E (1960) Collagen fractions in lathyritic rats. Biochem Pharmacol 3:181–183PubMedCrossRef

53.

Lees S, Barnard S, Mook H (1987) Neutron studies of collagenic lathyritic bone. Int J Biol Macromol 9:32–38CrossRef

54.

Rauch F, Glorieux FH (2004) Osteogenesis imperfecta. Lancet 363:1377–1385PubMedCrossRef

55.

Rauch F, Travers R, Parfitt AM, Glorieux FH (2000) Static and dynamic bone histomorphometry in children with osteogenesis imperfecta. Bone 26:581–589PubMedCrossRef

56.

Eyre DR, Weis MA (2013) Bone collagen: new clues to its mineralization mechanism from recessive osteogenesis imperfecta. Calcif Tissue Int 93:338–347PubMedCentralPubMedCrossRef

57.

Cassela JP, Yousuf Ali S (1992) Abnormal collagen and mineral formation in osteogenesis imperfecta. Bone Miner 17:123–128CrossRef

58.

Cassela JP, Stamp TCB, Ali SY (1996) A morphological and ultrastructural study of bone in osteogenesis imperfecta. Calcif Tissue Int 58:155–165CrossRef

59.

Sarathchandra P, Pope FM, Ali SY (1999) Morphometric analysis of type I collagen fibrils in the osteoid of osteogenesis imperfecta. Calcif Tissue Int 65:390–395PubMedCrossRef

60.

Kirsch E, Krieg T, Remberger K, Fendel H, Bruckner P, Muller PK (1981) Disorder of collagen metabolism in a patient with osteogenesis imperfecta (lethal type): increased degree of hydroxylation of lysine in collagen type I and III. Eur J Clin Invest 11:39–47PubMedCrossRef

61.

Garnero P, Schott AM, Prockop D, Chevrel G (2009) Bone turnover and type I collagen C-telopeptide isomerization in adult osteogenesis imperfecta: associations with collagen gene mutations. Bone 44:461–466PubMedCrossRef

62.

Chipman SD, Sweet HO, McBride DJ Jr, Davisson MT, Marks SC Jr, Shuldiner AR, Wenstrup RJ, Rowe DW, Shapiro JR (1993) Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta. Proc Natl Acad Sci USA 90:1701–1705PubMedCentralPubMedCrossRef

63.

Bonadio J, Saunders TL, Tsai E, Goldstein SA, Morris-Wiman J, Brinkley L, Dolan DF, Altschuler RA, Hawkins JE Jr, Bateman JF (1990) Transgenic mouse model of the mild dominant form of osteogenesis imperfecta. Proc Natl Acad Sci USA 87:7145–7149PubMedCentralPubMedCrossRef

64.

Forlino A, Porter FD, Lee EJ, Westphal H, Marini JC (1999) Use of the Cre/lox recombination system to develop a non-lethal knock-in murine model for osteogenesis imperfecta with an alpha1(I) G349C substitution. Variability in phenotype in Brtl IV mice. J Biol Chem 274:37923–37931PubMedCrossRef

65.

Morello R, Bertin TK, Chen Y, Hicks J, Tonachini L, Monticone M, Castagnola P, Rauch F, Glorieux FH, Vranka J, Bächinger HP, Pace JM, Schwarze U, Byers PH, Weis M, Fernandes RJ, Eyre DR, Yao Z, Boyce BF, Lee B (2006) CRTAP is required for prolyl 3-hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell 127:291–304PubMedCrossRef

66.

Sims TJ, Miles CA, Bailey AJ, Camacho NP (2003) Properties of collagen in oim mouse tissues. Connect Tissue Res 44(Suppl 1):202–205PubMedCrossRef

67.

Miller E, Delos D, Baldini T, Wright TM, Camacho NP (2007) Abnormal mineral-matrix interactions are a significant contributor to fragility in oim/oim bone. Calcif Tissue Int 81:206–214CrossRef

68.

Jepsen KJ, Goldstein SA, Kuhn JL, Schaffler MB, Bonadio J (1996) Type-I collagen mutation compromises the post-yield behavior of Mov13 long bone. J Orthop Res 14:493–499PubMedCrossRef

69.

Kuznetsovaa NV, Forlinob A, Cabralb WA, Marinib JC, Leikina S (2004) Structure, stability and interactions of type I collagen with GLY349-CYS substitution in α1(I) chain in a murine Osteogenesis Imperfecta model. Matrix Biol 23:101–112CrossRef

70.

Wallace JM, Orr BG, Marini JC, Banaszak Holl MM (2011) Nanoscale morphology of type I collagen is altered in the Brtl mouse model of Osteogenesis Imperfecta. J Struct Biol 173:146–152PubMedCentralPubMedCrossRef

71.

Gutsmann T, Fantner GE, Kindt JH, Venturoni M, Danielsen S, Hansma PK (2004) Force spectroscopy of collagen fibers to investigate their mechanical properties and structural organization. Biophys J 86:3186–3193PubMedCentralPubMedCrossRef

72.

van der Rijt JAJ, van der Werf KO, Bennink ML, Dijkstra PJ, Feijen J (2006) Micromechanical testing of individual collagen fibrils. Macromol Biosci 6:697–702PubMedCrossRef

73.

Wallace JM, Erickson B, Les CM, Orr BG, Banaszak Holl MM (2010) Distribution of type I collagen morphologies in bone: relation to estrogen depletion. Bone 46:1349–1354PubMedCentralPubMedCrossRef

74.

Meunier PJ, Coindre JM, Edouard CM, Arlot ME (1980) Bone histomorphometry in Paget’s disease. Quantitative and dynamic analysis of Pagetic and non-Pagetic bone tissue. Arthritis Rheum 23:1095–1103PubMedCrossRef

75.

Garnero P, Gineyts E, Schaffer AV, Seaman J, Delmas PD (1998) Measurement of urinary excretion of nonisomerized an beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget’s disease. Arthritis Rheum 41:354–360PubMedCrossRef

76.

Nagaoka H, Terajima M, Yamada S, Azuma Y, Chida T, Yamauchi M (2014) Alfacalcidol enhances collagen quality in ovariectomized rat bones. J Orthop Res 32:1030–1036PubMedCentralPubMedCrossRef

77.

Saito M, Grynpas MD, Burr DB, Allen MR, Smith SY, Doyle N, Amizuka N, Hasegawa T, Kida Y, Marumo K, Saito H (2015) Treatment with eldecalcitol positively affects mineralization, microdamage, and collagen crosslinks in primate bone. Bone 73:8–15PubMedCrossRef

78.

Nyman JS, Ni Q, Nicolella DP, Wang X (2008) Measurements of mobile and bound water by nuclear magnetic resonance correlate with mechanical properties of bone. Bone 42:193–199PubMedCentralPubMedCrossRef

79.

Nyman JS, Roy A, Shen X, Acuna RL, Tyler JH, Wang X (2006) The influence of water removal on the strength and toughness of cortical bone. J Biomech 39:931–938PubMedCentralPubMedCrossRef

80.

Gallant MA, Brown DM, Hammond M, Wallace JM, Du J, Deymier-Black AC, Almer JD, Stock SR, Allen MR, Burr DB (2014) Bone cell-independent benefits of raloxifene on the skeleton: a novel mechanism for improving bone material properties. Bone 61:191–200PubMedCentralPubMedCrossRef

81.

Luo Q, Nakade R, Dong X, Rong Q, Wang X (2011) Effect of mineral–collagen interfacial behavior on the microdamage progression in bone using a probabilistic cohesive finite element model. J Mech Behav Biomed Mater 4:943–952PubMedCrossRef

82.

Garnero P, Cloos P, Sornay-Rendu E, Qvist P, Delmas PD (2002) Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: the OFELY prospective study. J Bone Miner Res 17:826–833PubMedCrossRef

83.

Hoshino H, Takahashi M, Kushida K, Ohishi T, Inoue T (1999) The relationships between the degree of beta-isomerization of type I collagen degradation products in the urine and aging, menopause and osteoporosis with fractures. Osteoporos Int 9:405–409PubMedCrossRef

84.

Bauer DC, Garnero P, Litwack S, Cauley JA, Ensrud K, Eastell R, Orwoll E (2010) Type I collagen isomerization (alpha/beta CTX ratio) and the risk of new vertebral fracture in men: a prospective study. J Bone Miner Res 25(Suppl 1):1024

85.

Byrjalsen I, Leeming DJ, Qvist P, Christiansen C, Karsdal MA (2008) Bone turnover and bone collagen maturation in osteoporosis: effects of antiresorptive therapies. Osteoporos Int 19:339–348PubMedCrossRef

86.

Garnero P, Bauer D, Mareau E, Bilezikian JP, Greenspan SL, Rosen C, Black D (2008) Effects of PTH and alendronate on type I collagen isomerization in postmenopausal women with osteoporosis: the PaTH study. J Bone Miner Res 23:1442–1448PubMedCentralPubMedCrossRef

87.

Kauppila S, Jukkola A, Melkko J, Risteli L, Turpeeniemi-Hujanen T, Vuorinen K, Risteli J (2001) Aminoterminal propeptide of the alpha1-homotrimer variant of human type I procollagen (hotPINP) in malignant pleural effusion. Anticancer Res 21(4A):2293–2296PubMed

Titel: The Role of Collagen Organization on the Properties of Bone
verfasst von: Patrick Garnero
Publikationsdatum: 01.09.2015
Verlag: Springer US
Erschienen in: Calcified Tissue International / Ausgabe 3/2015
Print ISSN: 0171-967X
Elektronische ISSN: 1432-0827
DOI: https://doi.org/10.1007/s00223-015-9996-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

19.04.2024 | Vorhofflimmern | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

The Role of Collagen Organization on the Properties of Bone

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2015

The Mineral–Collagen Interface in Bone

Bone Material Properties and Skeletal Fragility

Effects of Collagen Crosslinking on Bone Material Properties in Health and Disease

Fragility of Bone Material Controlled by Internal Interfaces

Erratum to: The Role of Collagen Organization on the Properties of Bone

The Role of Water Compartments in the Material Properties of Cortical Bone

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Innere Medizin